Amsali, Ziyan .

HRN: 28-13-67  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/20/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/20/2025
12/06/2025
IVT
1.25gm
Q8
Pneumonia
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines